OptiNose

$3.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) Today

-$0.06 (-1.71%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell OptiNose and other stocks, options, and ETFs commission-free!

About OPTN

OptiNose, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. Its products include the XHANCE and ONZETRA Xsail. The company was founded by Per Gisle Djupesland and Helena Kyttari Djupesland in October 2000 and is headquartered in Yardley, PA. The listed name for OPTN is OptiNose, Inc. Common Stock.

CEO

Peter Kaighn Miller

Employees

204

Headquarters

Yardley, Pennsylvania

Founded

2000

Market Cap

201.72M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

708.05K

High Today

$3.59

Low Today

$3.31

Open Price

$3.50

Volume

656.04K

52 Week High

$10.00

52 Week Low

$3.14

OPTN News

BenzingaMar 3

Recap: OptiNose Q4 Earnings

Shares of OptiNose (NASDAQ:OPTN) decreased 0.8% in pre-market trading after the company reported Q4 results. Quarterly Results Earnings per share rose 20.69%

BenzingaMar 3

OptiNose, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 3, 2021 / OptiNose, Inc. (NASDAQ:OPTN) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to

BenzingaMar 2

Earnings Preview for OptiNose

OptiNose (NASDAQ:OPTN) unveils its next round of earnings this Wednesday, March 03. Here is Benzinga's everything-that-matters guide for the earnings announceme

OPTN Earnings

-$0.74

-$0.64

-$0.53

-$0.43

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Estimated

-$0.46 per share

Actual

-$0.46 per share

Replay Earnings Call